Rapid Micro Biosystems, Inc. Class A RPID

NASDAQProducer ManufacturingUnited States

$0.6510-0.02 (-2.98%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 0.640.67
52-week range: 0.584.94

Financial health

– / 5

Analyst view · 4 firms

Buy4 buy · 0 hold · 0 sell

Avg. target $6.00 (+821.7%)

Prices may be delayed and are for informational purposes only - not investment advice.

Rapid Micro Biosystems, Inc. Class A RPID

NASDAQProducer ManufacturingUnited States

$0.6510-0.02 (-2.98%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 0.640.67
52-week range: 0.584.94

Financial health

– / 5

Analyst view · 4 firms

Buy4 buy · 0 hold · 0 sell

Avg. target $6.00 (+821.7%)

Valuation from filings

Calculated from the tables below and the current price ($0.6510) · LTM · 2026/6 · 2026-06-30

P/E: —EPS $-1.12
P/B: 1.70BV/share $0.38
P/S: 0.86Sales/share $0.76
Return on equity: -288.5%Net income / equity
Net margin: -145.6%Operating margin -141.5%
Free cash flow yield: -123.7%Free cash flow / market cap

Revenue and net income

Fiscal year · $ millions · net margin below

RevenueNet Income

Financial statements

$ thousands · Under each value: change against a year earlier

Upgrade to MakklerPRO to see every row.Upgrade to MakklerPRO

Fiscal year	2021	2022	2023	2024	2025	LTM
Income Statement
Revenue	23,232	17,133-26%	22,519+31%	28,051+25%	33,587+20%	35,176
Operating expenses
Operating Income
EBITDA
Pre-tax income
Income tax (expense) / benefit
Net Income	(73,524)	(60,806)-17%	(52,467)-14%	(46,889)-11%	(47,123)0%	(51,200)
Earnings per share ($)
Margins
Operating margin
EBITDA margin
Net margin

Taken from the company's own 10-K and 10-Q filings via the SEC's XBRL data service. The "LTM" column is the last completed fiscal year plus the current year to date, minus the same period a year earlier. Lines a company tags with a non-standard label are left blank rather than filled with an approximation. Not investment advice.